EU is financing 2 programmes with the SADC, i.e. the SIPS and SIBE programmes. For both programmes Mauritian Companies are eligible.
The service tender was relaunched and we are hopeful that the contracts will be signed by end of September and activities which can be implemented remotely will start.
Regarding the SIPS programme, we have worked to redirect some of the funds to the response to COVID (see infographics and concept note attached).
The call for innovative projects for the local manufacturing of COVID-19-relevant medical and pharmaceutical products was published on Monday. This includes, but is not limited to, personal protective equipment, sanitisers and disinfectants, ventilators and related equipment, and pharmaceuticals related to the prevention and treatment of COVID-19.
The call is part of the COVID-19 response package developed by the EU, the SADC Secretariat and Germany to respond to the COVID pandemic.
This support is targeted at private and public sector companies and initiatives (e.g. University initiatives, national technology initiatives) in the SADC region with innovative projects for the manufacturing of COVID-19-relevant medical and pharmaceutical products. The financial grant per successful single applicant is expected to range from EUR 50,000 to EUR 100,000 for for-profit companies, and from EUR 100,000 to EUR 200,000 for non-profit making initiative.
Interested applicant can apply until the 24 August 2020.
For all details, please find the link to the call here. https://www.sadc.int/…/project-production-covid-19-relevan…/